AFJKR Aimei Health Technology Co., Ltd.
Fundamentals / CIK 0001979005 / USDAimei Health Technology Co., Ltd. reported $12.79M in total assets and net income of $30K through December 31, 2025 from SEC EDGAR filings.
Audited annual (10-K / 20-F) and quarterly (10-Q) statements parsed directly from SEC EDGAR CompanyFacts. Open AFJKR in the Convexity terminal for live prices, valuation multiples, transcripts, and insider flow.
-
Revenue FY 2025-- Dec 31, 2025
-
Operating Income FY 2025-$650K Operating profit
-
Net Income FY 2025$30K GAAP bottom line
-
Diluted EPS FY 2025-- Split-adjusted
-
Free Cash Flow FY 2025-- Operating CF less CapEx
-
Cash & ST Investments Sep 30, 2026$3.4K Total debt: --
Annual revenue and net income
2 fiscal years (2024 to 2025), reported in USD.
Financial statements and ratios
Reported in USD. Per-share figures and share counts are adjusted for stock splits from SEC filings.
Income Statement (Annual) · Reported in USD · Newest filing period first.
| Income Statement | Dec 31 | Dec 31 |
|---|---|---|
| Operating Income | -$836K | -$1.06M |
| Income Tax Expense | $0 | $0 |
| Net Income | $1.06M | $2.55M |
Income Statement (Quarterly) · Reported in USD · Newest filing period first.
| Income Statement | 2026-09-30 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
|---|---|---|---|---|---|---|---|---|
| Operating Income | -$145K | -$192K | -$62K | -$251K | -$130K | -$42K | -$413K | -$402K |
| Income Tax Expense | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Net Income | -$31K | -$83K | $45K | $98K | $352K | $425K | $185K | $444K |
Balance Sheet (Annual) · Reported in USD · Newest filing period first.
| Balance Sheet | Dec 31 | Dec 31 | Dec 31 |
|---|---|---|---|
| Cash & Cash Equivalents | $2.9K | $28K | $581K |
| Cash & Short-Term Investments | $2.9K | $28K | $581K |
| Total Current Assets | $2.9K | $30K | $581K |
| Total Non-Current Assets | $12.10M | $73.78M | $69.89M |
| Total Assets | $12.10M | $73.81M | $70.47M |
| Other Current Liabilities | $900K | $290K | -- |
| Total Current Liabilities | $3.37M | $817K | $25K |
| Total Non-Current Liabilities | $690K | $690K | $690K |
| Total Liabilities | $4.06M | $1.51M | $715K |
| Common Stock | $213 | $213 | $213 |
| Retained Earnings | -$4.06M | -$1.48M | -$134K |
| Total Stockholders' Equity | -$4.06M | -$1.48M | -$134K |
| Total Equity | -$4.06M | -$1.48M | -$134K |
Balance Sheet (Quarterly) · Reported in USD · Newest filing period first.
| Balance Sheet | 2026-09-30 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
|---|---|---|---|---|---|---|---|---|
| Cash & Cash Equivalents | $3.4K | $1.5K | $19K | $2.9K | $3.0K | $2.1K | $7.3K | $28K |
| Cash & Short-Term Investments | $3.4K | $1.5K | $19K | $2.9K | $3.0K | $2.1K | $7.3K | $28K |
| Total Current Assets | $51K | $44K | $19K | $2.9K | $25K | $45K | $8.0K | $30K |
| Total Non-Current Assets | $12.74M | $12.49M | $12.28M | $12.10M | $45.44M | $44.51M | $43.59M | $73.78M |
| Total Assets | $12.79M | $12.53M | $12.29M | $12.10M | $45.47M | $44.56M | $43.60M | $73.81M |
| Other Current Liabilities | $1.48M | $1.13M | $990K | $900K | $826K | $699K | $473K | $290K |
| Total Current Liabilities | $4.13M | $3.84M | $3.52M | $3.37M | $2.77M | $2.21M | $1.69M | $817K |
| Total Non-Current Liabilities | $690K | $690K | $690K | $690K | $690K | $690K | $690K | $690K |
| Total Liabilities | $4.82M | $4.53M | $4.21M | $4.06M | $3.46M | $2.90M | $2.38M | $1.51M |
| Common Stock | $213 | $213 | $213 | $213 | $213 | $213 | $213 | $213 |
| Retained Earnings | -$4.77M | -$4.48M | -$4.19M | -$4.06M | -$3.44M | -$2.86M | -$2.37M | -$1.48M |
| Total Stockholders' Equity | -$4.77M | -$4.48M | -$4.19M | -$4.06M | -$3.44M | -$2.86M | -$2.37M | -$1.48M |
| Total Equity | -$4.77M | -$4.48M | -$4.19M | -$4.06M | -$3.44M | -$2.86M | -$2.37M | -$1.48M |
Cash Flow Statement (Annual) · Reported in USD · Newest filing period first.
| Cash Flow Statement | Dec 31 | Dec 31 |
|---|---|---|
| Net Income | $1.06M | $2.55M |
| Operating Cash Flow | -$565K | -$672K |
| Investing Cash Flow | $63.58M | -$278K |
| Share Repurchases | -$65.33M | -- |
| Financing Cash Flow | -$63.04M | $397K |
| Net Change in Cash | -$25K | -$553K |
Cash Flow Statement (Quarterly) · Reported in USD · Newest filing period first.
| Cash Flow Statement | 2026-09-30 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
|---|---|---|---|---|---|---|---|---|
| Net Income | -$31K | -$83K | $45K | $98K | $352K | $425K | $185K | $444K |
| Operating Cash Flow | -$346K | -$157K | -$75K | -$43K | -$96K | -$202K | -$224K | -$195K |
| Investing Cash Flow | -$137K | -$103K | -$69K | $33.69M | -$450K | -$450K | $30.79M | -- |
| Share Repurchases | -- | -- | -- | -$34.06M | $0 | $0 | -$31.27M | -- |
| Financing Cash Flow | $486K | $243K | $159K | -$33.65M | $547K | $647K | -$30.58M | -- |
| Net Change in Cash | $1.9K | -$17K | $16K | -$50 | $841 | -$5.2K | -$21K | -$75K |
Margins, returns, leverage, liquidity, and year-over-year growth computed directly from SEC EDGAR statement levels. Multi-year figures show cumulative per-share growth.
| Ratios & Growth | Dec 31 | Dec 31 |
|---|---|---|
| Return on Assets (ROA) | 8.8% | 3.5% |
| Current Ratio | 0.00x | 0.04x |
| Quick Ratio | 0.00x | 0.03x |
| Net Income Growth (YoY) | -58.5% | -- |
Quarterly margins, ROE, and ROA use trailing-twelve-month (TTM) flows summed across four contiguous quarters. Growth rates are true year-over-year comparisons against the same quarter a year earlier.
| Ratios & Growth | 2026-09-30 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
|---|---|---|---|---|---|---|---|---|
| Return on Assets (ROA) | 0.2% | 3.3% | 7.5% | 8.8% | 3.1% | 4.0% | 4.5% | 3.5% |
| Current Ratio | 0.01x | 0.01x | 0.01x | 0.00x | 0.01x | 0.02x | 0.00x | 0.04x |
| Quick Ratio | 0.00x | 0.00x | 0.01x | 0.00x | 0.00x | 0.00x | 0.00x | 0.03x |
| Net Income Growth (YoY) | -108.8% | -119.6% | -75.4% | -77.9% | -52.7% | -30.2% | -75.6% | +153.8% |